Individual microparticles are coated with a full HLA class I (HLA-A, -B and -C antigens) or HLA class II type (HLA-DR, -DQB, -DQA and -DP antigens). The specificity assay based on flow cytometry ...

large cell panels were necessary to provide coverage for detecting the most common HLA antigens. Rare or unusual antigens were frequently not included in most clinical laboratory panels ...

The transplant process begins with a human leukocyte antigen typing blood test to determine donor-recipient compatibility for ...

Regulators approved the first bespoke cell therapies for solid tumors this year, while drugmakers expanded and improved upon ...

Celebrate advancements in bone marrow transplantation in India, offering hope and life-saving treatments for patients ...

Teprotumumab (Tepezza), an insulin-like growth factor type 1 receptor antagonist, was approved for treatment of thyroid eye disease in 2020. Teprotumumab is administered intravenously every 3 weeks ...

The pharmaceutical industry is buzzing with innovation, driven by the need for new treatments, tackling unmet medical ...

引言近年来，免疫治疗作为治疗癌症、感染性疾病以及自身免疫疾病的一种新兴策略，展现了巨大的潜力。然而，其核心挑战在于如何实现对病变细胞的精准识别和杀伤。传统的免疫疗法多依赖于单一靶点，如肿瘤表面特异性抗原，但这种方法易导致靶点突变或逃逸，使治疗效果大打 ...

Upadacitinib vs placebo demonstrated lasting efficacy and safety over 52-weeks of treatment among patients with nr-axSpA.

We recently compiled a list of the Top 11 CRISPR Stocks to Invest In. In this article, we are going to take a look at where Caribou Biosciences Inc.

GEN uncovers seven biopharma-related trends based on interviews with experts and other industry stakeholders, as well as ...